5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 36.32▲ | 36.35▼ | 36.31▲ | 35.67▲ | 36.83▼ |
MA10 | 36.30▲ | 36.31▲ | 36.13▲ | 36.06▲ | 37.72▼ |
MA20 | 36.35▼ | 36.05▲ | 35.93▲ | 36.75▼ | 38.04▼ |
MA50 | 36.32▲ | 35.68▲ | 35.36▲ | 38.03▼ | 42.52▼ |
MA100 | 36.15▲ | 35.45▲ | 36.28▲ | 37.96▼ | 37.67▼ |
MA200 | 35.89▲ | 36.40▼ | 37.22▼ | 41.78▼ | 30.72▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.006▼ | 0.002▲ | 0.057▲ | -0.019▼ | -0.142▼ |
RSI | 50.522▲ | 57.797▲ | 58.839▲ | 46.324▼ | 42.296▼ |
STOCH | 70.310 | 60.875 | 66.270 | 33.949 | 22.465 |
WILL %R | -31.818 | -52.041 | -31.776 | -49.565 | -73.023 |
CCI | 23.676 | 20.699 | 69.859 | 2.582 | -139.606▼ |
Wednesday, August 13, 2025 12:37 PM
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best upside stocks to invest in now. Earlier on July 23, Revolution Medicines announced that the US FDA granted Breakthrough Therapy Designation ...
|
Thursday, August 07, 2025 02:50 AM
Revolution Medicines Q2 2025 earnings call highlights breakthroughs in RAS-targeted cancer therapies, global expansion plans, strong financial backing & ...
|
Wednesday, July 30, 2025 02:30 PM
REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 36.84 | 36.8401 | 35.82 | 36.32 | 1,391,929 |
14/08/25 | 35.65 | 36.25 | 35.22 | 36.02 | 2,807,778 |
13/08/25 | 35.30 | 36.24 | 34.88 | 36.07 | 2,412,059 |
12/08/25 | 34.82 | 35.60 | 34.21 | 35.26 | 2,516,990 |
11/08/25 | 34.88 | 35.18 | 34.14 | 34.70 | 1,524,533 |
08/08/25 | 35.00 | 35.93 | 34.31 | 35.00 | 3,790,295 |
07/08/25 | 34.18 | 36.16 | 34.00 | 34.95 | 3,793,906 |
06/08/25 | 37.96 | 38.33 | 36.39 | 36.67 | 1,767,686 |
05/08/25 | 37.00 | 38.60 | 36.54 | 38.39 | 1,793,618 |
04/08/25 | 36.68 | 37.26 | 36.20 | 37.18 | 842,415 |
|
|
||||
|
|
||||
|
|